STAT

STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study

STAT+: Novartis’ experimental cardiovascular drug fails a pivotal studyWorldPing

A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the firm.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

More coverage: all health news on WorldPing.

Related news